Bupropion Hydrochloride Extended-Release Tablets
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Bupropion Hydrochloride Extended-Release Tablets contain NLT 90.0% and NMT 110.0% of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl).
2 IDENTIFICATION
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197K
Sample: Crush 1 Tablet using a mortar and pestle. Prepare an approximate 1% (w/w) dispersion of the sample in potassium bromide.
Acceptance criteria: The Sample shows strong bands at about 1690, 1560, and 1240 cm-1 and a weaker band at about 740 cm-1, similar to the reference preparation.
B. The retention time of the major peak of Sample solution A or Sample solution B corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Change to read:
PROCEDURE
Diluent 1: Methanol and 0.001 N hydrochloric acid TS (20:80)
Solution A: Acetonitrile, trifluoroacetic acid, and water (10:0.04:90)
Solution B: Acetonitrile, trifluoroacetic acid, and water (95: 0.03:5)
Mobile phase: See Table 1.
Table 1
Time (min) | Solution A (%) | Solution B (%) |
| 0 | 90 | 10 |
| 3.4 | 87 | 13 |
| 10.0 | 15 | 85 |
| 10.1 | 0 | 100 |
| 13.0 | 0 | 100 |
| 13.2 | 90 | 10 |
| 19.0 | 90 | 10 |
System suitability stock solution: 0.02 mg/mL of USP Bupropion Related Compound C RS and 0.2 mg/mL of USP Bupropion Related Compound F RS in methanol
System suitability solution: 0.002 mg/mL of bupropion related compound C and 0.02 mg/mL of bupropion related compound F from the System suitability stock solution in Diluent 1
Standard solution: 0.6 mg/ml of USP Bupropion Hydrochloride RS in Diluent 1
Sample stock solution A: Transfer a number of Tablets, intact or crushed, to a suitable homogenizer vessel containing sufficient methanol to obtain a concentration of 3.0 mg/ml. of bupropion hydrochloride. Immediately homogenize the sample for 30 s at 20,000 rpm. Allow extraction for 3 min, and follow by two additional 10-s pulses, each at 20,000 rpm, pausing 3 min between these pulses to ensure complete extraction. Pass a portion of the solution through a nylon filter of 0.45-um pore size, discarding the first 2-4 mL of the filtrate.
Sample solution A: Nominally 0.6 mg/mL of bupropion hydrochloride from Sample stock solution A in 0.001 N hydrochloric acid TS Alternatively, the Sample solution can be prepared as follows.
Buffer: Dissolve 100 g of anhydrous dibasic sodium phosphate in 1 L of water. Add 50 mL of phosphoric acid, stir or sonicate until dissolved, and mix. Adjust with phosphoric acid to a pH of 3.0.
Diluent 2: Methanol and Buffer (20:80)
Sample stock solution B: Weigh and grind NLT 20 Tablets to prepare a solution having a nominal concentration of 3 mg/mL. Initially add Diluent 2 (75% of the volume of the flask), stir for 30 min, and sonicate for 15 min. Dilute with Diluent 2 to volume. Centrifuge a portion of the resulting solution, and use the supernatant.
Sample solution B: Nominally 0.6 mg/ml of bupropion hydrochloride from Sample stock solution B in Diluent 2
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 226 nm
Column: 4.6-mm x 10-cm; 3.5-µm packing 11
Column temperature: 40°
Flow rate: 1.5 mL/min
Injection volume: 5 µL
System suitability
Samples: System suitability solution and Standard solution
[NOTE-See Table 30 (RB 1-Aug-2023) for the relative retention times.]
Suitability requirements
Resolution: NLT 1.3 between bupropion related compound F and bupropion related compound C, System suitability solution
Tailing factor: NMT 1.9, Standard solution
Relative standard deviation: NMT 1.0%, Standard solution
Analysis
Samples: Standard solution and Sample solution A or Sample solution B
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) in the portion of Tablets taken:
Result = (ru /rs ) × (Cs /Cu ) × 100
ru = peak response of bupropion hydrochloride from Sample solution A or Sample solution B
rs = peak response of bupropion hydrochloride from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
Cu = nominal concentration of bupropion hydrochloride in Sample solution A or Sample solution B (mg/mL)
Acceptance criteria: 90.0%–110.0%
4 PERFORMANCE TESTS
Change to read:
Dissolution 〈711〉
For products labeled for dosing every 12 h
Test 1
Medium: Water; 900 mL, deaerated, if necessary
Apparatus 2: 50 rpm
Times: 1, 4, and 8 h
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet. Dilute with
Medium, if necessary.
Sample solution: Pass a portion of the solution under test through a suitable lter, and dilute with Medium, if necessary.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy 〈857〉.)
Mode: UV-Vis
Analytical wavelength: 298 nm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (C ) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Au /As ) × Cs × D
Au = absorbance from the Sample solution at time point i
As = absorbance from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
D = dilution factor for the Sample solution, if needed
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = {[C2 × (V − Vs )] + (C1 × Vs )} × (1/L) × 100
Result3 = ({C3 × [V − (2 × Vs )]} + [(C2 + C1 ) × Vs ]) × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn at each time point (mL)
Tolerances: See Table 2.
Table 2
Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 1 | 25–50 |
| 2 | 4 | 60–90 |
| 3 | 8 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to
Dissolution (711), Acceptance Table 2.
Test 2: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.
Medium: 0.1 N hydrochloric acid, pH 1.5 (prepared by transferring 50 mL of hydrochloric acid to 6000 mL of water, adding 18 g of sodium hydroxide, mixing, and adjusting with either diluted sodium hydroxide or hydrochloric acid to a pH of 1.5); 900 mL, deaerated
Apparatus 1: 50 rpm
Times: 1, 2, 4, and 6 h
Buffer: 3.45 g of monobasic sodium phosphate in 996 mL of water. Add 4.0 ml. of triethylamine, and adjust with phosphoric acid to a pH of 2.80.
Mobile phase: Methanol and Buffer (35:65)
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet
Sample solution: Use portions of the solution under test, and pass through a nylon filter of 0.45-µm pore size.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 298 nm
Column: 4.6-mm x 15-cm; packing 11
Flow rate: 1 mL/min
Injection volume: 20 µL
System suitability
Sample: Standard solution
Suitability requirements
Column efficiency: NLT 2000 theoretical plates
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Determine the percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved.
Tolerances: See Table 3.
Table 3
Time (h) | Amount Dissolved (%) |
| 1 | 25–50 |
| 2 | 40–65 |
| 4 | 65–90 |
| 6 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to
Dissolution (711), Acceptance Table 2.
Test 3: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 3.
Medium: Water: 900 mL
Apparatus 2: 50 rpm. Use wire coil sinkers, if necessary.
Times: 1, 2, 4, and 6 h
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet. Dilute with Medium, if necessary.
Sample solution: Pass a portion of the solution under test through a suitable filter, and dilute with Medium, if necessary.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength: 250 nm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Determine the percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved.
Tolerances: See Table 4.
Table 4
| Time (h) | Amount Dissolved (for Tablets that contain 200 mg of bupropion hydrochloride) (%) | Amount Dissolved (for Tablets that contain all other strengths of bupropion hydrochloride) (%) |
| 1 | 30–50 | 30–55 |
| 2 | 45–65 | 50–75 |
| 4 | 65–85 | 70–90 |
| 6 | NLT 78 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to
Dissolution (711), Acceptance Table 2.
Test 5: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 5.
Medium: Water: 900 mL
Apparatus 2: 50 rpm
Times: 1, 3, and 6 h
Standard solution: (L / 900) * mg / m * L of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet. Dilute with Medium, if necessary.
Sample solution: Pass a portion of the solution under test through a suitable filter, and dilute with Medium, if necessary.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength: 298 nm
Cell: 0.5 cm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Determine the percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved.
Tolerances: See Table 5.
Table 5
Time (h) | Amount Dissolved (%) |
| 1 | 35–55 |
| 3 | 65–85 |
| 6 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to
Dissolution (711). Acceptance Table 2.
Test 7: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 7.
Medium: 0.1 N hydrochloric acid, pH 1.5 (prepared by transferring 50 mL of hydrochloric acid to 6000 mL of water, adding 18 g of sodium hydroxide, mixing, and adjusting with either diluted sodium hydroxide or hydrochloric acid to a pH of 1.5); 900 ml, deaerated
Apparatus 1: 50 rpm
Times: 1, 2, 4, and 6 h
Buffer: 3.45 g of monobasic sodium phosphate in 996 mL of water. Add 4.0 mL of triethylamine, and adjust with phosphoric acid to a pH of 2.80.
Mobile phase: Methanol and Buffer (45:55)
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet
Sample solution: Use portions of the solution under test, and pass through a nylon filter of 0.45-µm pore size.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 298 nm
Column: 4.6-mm x 15-cm; packing 11
Flow rate: 1 mL/min
Injection volume: 20 µL
System suitability
Sample: Standard solution
Suitability requirements
Column efficiency: NLT 2000 theoretical plates
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Determine the percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved.
Tolerances: See Table 6.
Table 6
Time (h) | Amount Dissolved (%) |
| 1 | 25–50 |
| 2 | 45–70 |
| 4 | NLT 70 |
| 6 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to
Dissolution (711), Acceptance Table 2.
Test 9: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 9.
Medium: 0.1 N hydrochloric acid, pH 1.5 (prepared by transferring 50 ml. of hydrochloric acid to 6000 mL of water, adding 18 g of sodium hydroxide, mixing, and adjusting with either diluted sodium hydroxide or hydrochloric acid to a pH of 1.5); 900 mL
Apparatus 1: 50 rpm
Times: 1, 2, 4, and 8 h
Standard solution: (L/1000) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet
Sample solution: Pass a portion of the solution under test through a suitable filter.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857),.)
Mode: UV-Vis
Analytical wavelength: 298 nm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Determine the percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved.
Tolerances: See Table Z.
Table 7
Time (h) | Amount Dissolved (%) |
| 1 | 20–45 |
| 2 | 35–55 |
| 4 | 55–85 |
| 8 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to
Dissolution (711), Acceptance Table 2.
Test 10: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 10.
Medium: Water, 900 mL
Apparatus 2: 50 rpm
Times: 1, 2, 4, and 8 h
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet
Sample solution: Pass a portion of the solution under test through a suitable filter.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857))
Mode: UV-Vis
Analytical wavelength: 298 nm
Cell: 0.5 cm
Blank: Medium
System suitability
Sample: Standard solution
Suitability requirements
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Resulti = (Ai/As ) × Cs × V × (1/L) × 100
Ai = absorbance of bupropion hydrochloride from the Sample solution at time point i
As = absorbance of bupropion hydrochloride from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Tolerances: See Table 8.
Table 8
Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 1 | 20–40 |
| 2 | 2 | 35–60 |
| 3 | 4 | 55–85 |
| 4 | 8 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to
Dissolution (711), Acceptance Table 2.
Test 17: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 17.
Medium: 0.1 N hydrochloric acid, pH 1.5 (prepared by transferring 50 mL of hydrochloric acid to 6 L of water containing 18 g of sodium hydroxide, mixing, and adjusting with either diluted sodium hydroxide or diluted hydrochloric acid to a pH of 1.5); 900 mL, deaerated
Apparatus 1: 50 rpm
Times: 1, 2, 4, and 8 h
Buffer: To each liter of water add 6.8 g of monobasic potassium phosphate. Adjust with phosphoric acid to a pH of 3.0.
Mobile phase: Methanol and Buffer (60:40)
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet, Sonication may be used to promote dissolution.
Sample solution: Pass a portion of the solution under test through a suitable filter. [NOTE-A 0.45-µm nylon membrane filter may be suitable .]
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 298 nm
Column: 4.6-mm x 15-cm; 5-µm packing 17
Flow rate: 1 mL/min
Injection volume: 25 µL
Run time: NLT 1.5 times the retention time of bupropion
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation : NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Result = (ri /rs ) × Cs
ri = peak response of bupropion from the Sample solution at time point i
rs = peak response of bupropion from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = {[C2 × (V − Vs )] + (C1 × Vs )} × (1/L) × 100
Result3 = ({C3 × [V − (2 × Vs )]} + [(C2 + C1 ) × Vs ]) × (1/L) × 100
Result4 = ({C4 × [V − (3 × Vs )]} + [(C3 + C2 + C1 ) × Vs ]) × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn at each time point (mL)
Tolerances: See Table 9.
Table 9
| Time Point (i) | Time (h) | Amount Dissolved (for Tablets that contain 100 mg of bupropion hydrochloride) (%) | Amount Dissolved (for Tablets that contain 150 mg or 200 mg of bupropion hydrochloride) (%) |
| 1 | 1 | 20–40 | 15-35 |
| 2 | 2 | 40 - 60 | 35-55 |
| 3 | 4 | 60 - 85 | 55-80 |
| 4 | 8 | MT85 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to
Dissolution (711), Acceptance Table 2.
Test 19: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 19.
Medium: Water, degassed; 900 mL
Apparatus 1: 50 rpm
Times: 1, 2, 4, and 8 h
Standard stock solution: 0.56 mg/mL of USP Bupropion Hydrochloride RS in Medium
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet
Sample solution: Pass a portion of the solution under test through a suitable filter of 10-um pore size.
Instrumental conditions.
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength: 298 nm
Cell: 1 cm
Blank: Medium
System suitability
Sample: Standard solution
Suitability requirements
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (7):
Resulti = (Ai/As ) × Cs × V × (1/L) × 100
Ai = absorbance of bupropion from the Sample solution at time point i
As = absorbance of bupropion from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Tolerances: See Table 10.
Table 10
| Time Point (i) | Time (h) | Amount Dissolved (for Tablets that contain 100 mg of bupropion hydrochloride) (%) | Amount Dissolved (for Tablets that contain 150 or 200 mg of bupropion hydrochloride) (%) |
| 1 | 1 | 32-52 | 25-45 |
| 2 | 2 | 50-70 | 45-65 |
| 3 | 4 | NLT 75 | 65-85 |
| 4 | 8 | NLT 85 | NLT 85 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to
Dissolution (711), Acceptance Table 2.
For products labeled for dosing every 24 h
Test 4: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 4.
Medium: 0.1 N hydrochloric acid: 900 mL, deaerated
Apparatus 1: 75 rpm
Times: 2, 4, 8, and 16 h
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet. Dilute with Medium, if necessary.
Sample solution: Pass a portion of the solution under test through a suitable filter, and dilute with Medium, if necessary.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength: 252 nm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Determine the percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved.
Tolerances: See Table 11.
Table 11
Time (h) | Amount Dissolved (%) |
| 2 | NMT 20 |
| 4 | 20-45 |
| 8 | 65-90 |
| 16 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to
Dissolution 〈711〉, Acceptance Table 2.
Test 6: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 6.
Medium: 0.1 N hydrochloric acid; 900 mL, deaerated
Apparatus 1: 75 rpm
Times: 1, 2, 4, 8, and 12 h
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet. Dilute with
Medium, if necessary.
Sample solution: Pass a portion of the solution under test through a suitable lter, and dilute with Medium, if necessary.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy 〈857〉.)
Mode: UV-Vis
Analytical wavelength: 298 nm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Determine the percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved.
Tolerances: See Table 12.
Table 12
Time (h) | Amount Dissolved (%) |
| 1 | 15-35 |
| 2 | 25-50 |
| 4 | 40-65 |
| 8 | 65-90 |
| 12 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to
Dissolution 〈711〉, Acceptance Table 2.
Test 8: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 8.
Acid stage medium: 0.1 N hydrochloric acid; 900 mL
Buffer stage medium: pH 6.8 phosphate buffer; 900 mL
Apparatus 1: 75 rpm
Times: 2 h in Acid stage medium; 3, 8, and 16 h in Buffer stage medium. The time in the Buffer stage medium includes the time in the Acid stage medium.
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Acid stage medium, where L is the label claim, in mg/Tablet
Sample solution: Pass a portion of the solution under test through a suitable lter of 0.45-µm pore size.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy 〈857〉.)
Mode: UV-Vis
Analytical wavelength: 298 nm
Cell: 0.5 cm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Determine the percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved.
Tolerances: See Table 13.
Table 13
Time (h) | Amount Dissolved (%) |
| 2 | NMT 10 |
| 3 | 10-30 |
| 8 | 60-90 |
| 16 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to
Dissolution 〈711〉, Acceptance Table 2.
Test 11: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 11.
Acid stage medium: 0.1 N hydrochloric acid; 750 mL
Buffer stage medium: pH 6.8 phosphate buffer (add 250 mL of 76 g/L tribasic sodium phosphate to the Acid stage medium, adjust with 2
N hydrochloric acid TS or 2 N sodium hydroxide TS to a pH of 6.8, if necessary); 1000 mL
Apparatus 2: 50 rpm
Times: 2 h in Acid stage medium; 3, 8, and 16 h in Buffer stage medium. The time in the Buffer stage medium includes the time in the Acid
stage medium.
Acid stage standard solution: 0.06 mg/mL of USP Bupropion Hydrochloride RS in Acid stage medium, Sonication may be used to aid in dissolution.
Buffer stage standard solution: 0.15 mg/mL of USP Bupropion Hydrochloride RS in Buffer stage medium. Sonication may be used to aid in dissolution.
Sample solution: Pass a portion of the solution under test through a suitable filter of 0.45-µm pore size.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength: 298 nm
Cell: 0.5 cm
Blank: Acid stage medium or Buffer stage medium
Analysis
Samples: Acid stage standard solution, Buffer stage standard solution, and Sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Ai/As ) × Cs
Ai = absorbance of bupropion hydrochloride from the Sample solution at time point i
As = absorbance of bupropion hydrochloride from the Acid stage standard solution or Buffer stage standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Acid stage standard solution or Buffer stage standard solution (mg/mL)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × VA × (1/L) × 100
Result2 = {[C2 × (VB − Vs )] + (C1 × Vs )} × (1/L) × 100
Result3 = ({C3 × [VB − (2 × Vs )]} + [(C2 + C1 ) × Vs ]) × (1/L) × 100
Result4 = ({C4 × [VB − (3 × Vs )]} + [(C3 + C2 + C1 ) × Vs ]) × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
VA = volume of Acid stage medium, 750 mL
L = label claim (mg/Tablet)
VB = volume of Buffer stage medium, 1000 mL
Vs = volume of Sample solution withdrawn from the Acid stage medium or Buffer stage medium (mL)
Tolerances: See Table 14.
Table 14
| Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 2 | NMT 10 |
| 2 | 3 | 10-30 |
| 3 | 8 | 55-85 |
| 4 | 16 | NLT 75 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to Dissolution (711), Acceptance Table 2.
Test 12: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 12.
Medium: 0.1 N hydrochloric acid; 900 mL
Apparatus 1: 75 rpm
Times: 2, 4, 8, and 12 h
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet
Sample solution: Withdraw at least 10 mL of the solution under test and pass through a suitable filter.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength: 252 nm
Cell
For Tablets labeled to contain 150 mg: 0.1 cm
For Tablets labeled to contain 300 mg: 0.05 cm
Blank: Medium
System suitability
Sample: Standard solution
Suitability requirements
Relative standard deviation:
NMT 3.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Ai/As ) × Cs
Ai = absorbance of bupropion hydrochloride from the Sample solution at time point i
As = absorbance of bupropion hydrochloride from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = {[C2 × (V − Vs )] + (C1 × Vs )} × (1/L) × 100
Result3 = ({C3 × [V − (2 × Vs )]} + [(C2 + C1 ) × Vs ]) × (1/L) × 100
Result4 = ({C4 × [V − (3 × Vs )]} + [(C3 + C2 + C1 ) × Vs ]) × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn from the Medium (mL)
Tolerances: See Table 15.
Table 15
| Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 2 | NMT 25 |
| 2 | 4 | 25-50 |
| 3 | 8 | 60-85 |
| 4 | 12 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to Dissolution (711), Acceptance Table 2.
Test 13: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 13.
Medium: 0.1 N hydrochloric acid: 900 mL, deaerated
Apparatus 1: 75 rpm
Times: 2, 4, 8, and 12 h
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet
Sample solution: Withdraw at least 10 mL of the solution under test and centrifuge. Use the supernatant.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength: 252 nm
Cell: 0.1 cm
Blank: Medium
System suitability
Sample: Standard solution
Suitability requirements
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Ai/As ) × Cs
Ai = absorbance of bupropion hydrochloride from the Sample solution at time point i
As = absorbance of bupropion hydrochloride from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = {[C2 × (V − Vs )] + (C1 × Vs )} × (1/L) × 100
Result3 = ({C3 × [V − (2 × Vs )]} + [(C2 + C1 ) × Vs ]) × (1/L) × 100
Result4 = ({C4 × [V − (3 × Vs )]} + [(C3 + C2 + C1 ) × Vs ]) × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn from the Medium (mL)
Tolerances: See Table 16.
Table 16
Time Point (i) | Time (h) | Amount Dissolved (150 mg/Tablet) (%) | Amount Dissolved (300 mg/ Tablet) (%) |
| 1 | 2 | NMT 25 | NMT 25 |
| 2 | 4 | 30-55 | 25-45 |
| 3 | 8 | 65-90 | 60-80 |
| 4 | 12 | NLT 80 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to Dissolution (711), Acceptance Table 2.
Test 14: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 14.
Medium: 0.1 N hydrochloric acid; 900 mL
Apparatus 1: 75 rpm
Times: 2, 4, 8, and 16 h
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet. If necessary, dilute the solution with Medium.
Sample solution: Pass a portion of the solution under test through a suitable filter. Replace the portion removed with the same volume of Medium. If necessary, dilute the filtrate with Medium.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength: 252 nm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Ai/As ) × Cs × D
Ai = absorbance from the Sample solution at time point i
As = absorbance from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
D = dilution factor for the Sample solution, if needed
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = [(C2 × V) + (C1 × Vs )] × (1/L) × 100
Result3 = {(C3 × V) + [(C2 + C1 ) × Vs ]} × (1/L) × 100
Result4 = {(C4 × V) + [(C3 + C2 + C1 ) × Vs ]} × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn at each time point and replaced with Medium (mL)
Tolerances: See Table 17.
Table 17
Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 2 | NMT 20 |
| 2 | 4 | 20-45 |
| 3 | 8 | 55-85 |
| 4 | 16 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to Dissolution 〈711〉, Acceptance Table 2.
Test 15: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 15.
Acid stage
Acid stage medium: 0.1 N hydrochloric acid, degassed; 900 mL
Apparatus 1: 100 rpm
Time: 2 h in Acid stage medium
Buffer: 3.5 g/L of monobasic sodium phosphate prepared as follows. Dissolve 3.45 g of monobasic sodium phosphate in 996 mL of water, add 4.0 mL of triethylamine, and adjust with phosphoric acid to a pH of 2.8.
Mobile phase: Methanol and Buffer (45:55)
Acid stage standard solution: 0.033 mg/mL of USP Bupropion Hydrochloride RS in Acid stage medium. Sonication may be used to promote dissolution.
Acid stage sample solution: Pass a portion of the solution under test through a suitable filter, discard the first 5 ml., and use the filtrate. Then discard the Tablets and remaining solution. [NOTE-A 0.45-µm nylon membrane filter may be suitable.]
Chromatographic system
(See Chromatography (621). System Suitability.)
Mode: LC
Detector: UV 298 nm
Column: 4.6-mm x 15-cm; 5-um packing 11
Flow rate: 1 mL/min
Injection volume: 10 µL
Run time: NLT 1.5 times the retention time of bupropion
System suitability
Sample: Acid stage standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Acid stage standard solution and Acid stage sample solution
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved:
Result = (ru /rs ) × Cs × V × (1/L) × 100
ru = peak response of bupropion from the Acid stage sample solution
rs = peak response of bupropion from the Acid stage standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Acid stage standard solution (mg/mL)
V = volume of Acid stage medium, 900 mL
L = label claim (mg/Tablet)
Buffer stage: Use fresh Tablets.
Buffer stage medium: pH 6.8 tribasic sodium phosphate buffer and 0.5% sodium lauryl sulfate (Dissolve 19 g of tribasic sodium phosphate in 1 L of water, add 7 mL of hydrochloric acid, and adjust with 0.2 N sodium hydroxide TS or dilute hydrochloric acid to a pH of 6.8. Add 5 g of sodium dodecyl sulfate. To promote dissolution, the resulting solution can be continuously stirred and heated to 41. Allow the solution to cool to 37o before use. Do not allow the temperature to fall below 36.5o before beginning the test.); 900 mL
Apparatus 1: 100 rpm
Times: 1, 2, 4, and 8 h
Buffer: 1.4 g/L of dibasic ammonium phosphate and 0.5 g/L of sodium 1-hexanesulfonate prepared as follows. Dissolve 1.4 g of dibasic ammonium phosphate and 0.5 g of sodium 1-hexanesulfonate in 1 L of water. To each 1 L of this solution, add 2.0 mL of triethylamine, and adjust with phosphoric acid to a pH of 7.0.
Mobile phase: Acetonitrile and Buffer (60:40)
Buffer stage standard solution: 0.33 mg/mL of USP Bupropion Hydrochloride RS in Buffer stage medium
Buffer stage sample solution: Pass a portion of the solution under test through a suitable filter, discard the first 5 ml, and use the filtrate.
Chromatographic system: Proceed as directed under the Acid stage.
System suitability
Sample: Buffer stage standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Buffer stage standard solution and Buffer stage sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (ri /rs ) × Cs
ri = peak response of bupropion from the Buffer stage sample solution at time point i
rs = peak response of bupropion from the Buffer stage standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Buffer stage standard solution (mg/mL)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = {[C2 × (V − Vs )] + (C1 × Vs )} × (1/L) × 100
Result3 = ({C3 × [V − (2 × Vs )]} + [(C2 + C1 ) × Vs ]) × (1/L) × 100
Result4 = ({C4 × [V − (3 × Vs )]} + [(C3 + C2 + C1 ) × Vs ]) × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Buffer stage medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Buffer stage sample solution withdrawn at each time point (mL)
Tolerances
Acid stage: NMT 10%; the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the time
specified conforms to Dissolution (711), Acceptance Table 3.
Buffer stage: See Table 18.
Table 18
Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 1 | 5-25 |
| 2 | 2 | 25-45 |
| 3 | 4 | 60-85 |
| 4 | 8 | NIT 85 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to Dissolution (711) Acceptance Table 2.
Test 16: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 16.
Medium: 0.1 N hydrochloric acid: 900 ml, deaerated
Apparatus 1: 75 rpm
Times: 2, 5, 8, and 16 h
Buffer: 3.5 g/L of monobasic sodium phosphate prepared as follows. Dissolve 3.45 g of monobasic sodium phosphate in 996 mL of water, add 4.0 mL of triethylamine, and adjust with phosphoric acid to a pH of 2.8.
Mobile phase: Methanol and Buffer (35:65)
Standard solution: 0.17 mg/ml. of USP Bupropion Hydrochloride RS in Medium. Sonication may be used to promote dissolution.
Sample solution: Pass a portion of the solution under test through a suitable filter, and discard NLT 1 mL. Dilute the filtrate with Medium if necessary. Replace the portion removed with the same volume of Medium. [NOTE-A 0.45-µm nylon membrane filter may be suitable.]
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 298 nm.
Column: 4.6 - mm x 15 - cm -µm packing 11
Column temperature: 30o
Flow rate: 1 mL/min
Injection volume: 20 µL
Run time: NLT 1.5 times the retention time of bupropion
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci ) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (ri /rs ) × Cs × D
ri = peak response of bupropion from the Sample solution at time point i
rs = peak response of bupropion from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
D = dilution factor for the Sample solution, if needed
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = [(C2 × V) + (C1 × Vs )] × (1/L) × 100
Result3 = {(C3 × V) + [(C2 + C1 ) × Vs ]} × (1/L) × 100
Result4 = {(C4 × V) + [(C3 + C2 + C1 ) × Vs ]} × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn at each time point and replaced with Medium (mL)
Tolerances: See Table 19.
Table 19
Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 2 | NMT 10 |
| 2 | 5 | 30-60 |
| 3 | 8 | 65-88 |
| 4 | 16 | NLT 85 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to Dissolution 〈711〉, Acceptance Table 2.
Test 18: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 18.
Medium: 0.1 N hydrochloric acid; 900 mL, deaerated
Apparatus 1: 75 rpm
Times: 2, 4, 8, and 16 h
Buffer: 6.8 g/L of monobasic potassium phosphate in water adjusted with phosphoric acid to a pH of 3.0
Mobile phase: Methanol and Buffer (60:40)
Standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Medium, where L is the label claim, in mg/Tablet. Sonication
may be used to promote dissolution.
Sample solution: Centrifuge a portion of the solution under test for 15 min.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 298 nm
Column: 4.6-mm × 15-cm; 5-µm packing L7
Flow rate: 1 mL/min
Injection volume: 25 µL
Run time: NLT 1.5 times the retention time of bupropion
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (C ) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (ri /rs ) × Cs
ri = peak response of bupropion from the Sample solution at time point i
rs = peak response of bupropion from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = {[C2 × (V − Vs )] + (C1 × Vs )} × (1/L) × 100
Result3 = ({C3 × [V − (2 × Vs )]} + [(C2 + C1 ) × Vs ]) × (1/L) × 100
Result4 = ({C4 × [V − (3 × Vs )]} + [(C3 + C2 + C1 ) × Vs ]) × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn at each time point (mL)
Tolerances: See Table 20.
Table 20
Time Point (i) | Time (h) | Amount Dissolved (for Tablets that contain 150 mg of bupropion hydrochloride) (%) | Amount Dissolved (for Tablets that contain 300 mg of bupropion hydrochloride) (%) |
| 1 | 2 | NMT 20 | NMT 20 |
| 2 | 4 | 25-50 | 25-50 |
| 3 | 8 | 65-95 | 60-85 |
| 4 | 16 | NLT 80 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to Dissolution 〈711〉, Acceptance Table 2.
Test 20: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 20.
Medium: 0.1 N hydrochloric acid VS; 900 mL, deaerated
Apparatus 1: 75 rpm
Times: 2, 4, 8, and 16 h
Standard solution: 0.1 mg/mL of USP Bupropion Hydrochloride RS in Medium
Sample solution: Pass a portion of the solution under test through a suitable lter, and dilute with Medium, if necessary. Replace the
portion removed with the same volume of Medium.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy 〈857〉.)
Mode: UV-Vis
Analytical wavelength: 298 nm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci ) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Ai/As ) × Cs × D
Ai = absorbance from the Sample solution at time point i
As = absorbance from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
D = dilution factor for the Sample solution, if needed
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = [(C2 × V) + (C1 × Vs )] × (1/L) × 100
Result3 = {(C3 × V) + [(C2 + C1 ) × Vs ]} × (1/L) × 100
Result4 = {(C4 × V) + [(C3 + C2 + C1 ) × Vs ]} × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn at each time point and replaced with Medium (mL)
Tolerances: See Table 21.
Table 21
| Time Point (i) | Time (h) | Amount Dissolved (for Tablets that contain 150 mg of bupropion hydrochloride) (%) | Amount Dissolved (for Tablets that contain 300 mg of bupropion hydrochloride) (%) |
| 1 | 2 | NMT 15 | NMT 15 |
| 2 | 4 | 10-35 | 10-35 |
| 3 | 8 | 55-80 | 50-75 |
| 4 | 16 | NLT 80 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C H ClNO · HCl) dissolved at the times specied conform to Dissolution 〈711〉, Acceptance Table 2.
Test 21: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 21.
Medium: 0.1 N hydrochloric acid VS; 900 mL, deaerated
Apparatus 1: 75 rpm
Times: 4, 8, and 16 h
Standard stock solution 1: 0.84 mg/mL of USP Bupropion Hydrochloride RS prepared as follows. Transfer a suitable amount of USP Bupropion Hydrochloride RS to an appropriate volumetric flask. Add 50% of the flask volume of acetonitrile. Dilute with water to volume.
Standard stock solution 2: 0.17 mg/mL of USP Bupropion Hydrochloride RS from Standard stock solution 1 in Medium
Standard solution: 0.017 mg/mL of USP Bupropion Hydrochloride RS from Standard stock solution 2 in Medium passed through a suitable filter of 0.45-µm pore size
Sample solution: Dilute a portion of the solution under test with Medium. Pass a portion of the resulting solution through a suitable filter of 0.45-µm pore size. Replace the portion removed with the same volume of Medium.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength: 252 nm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Ai/As ) × Cs × D
Ai = absorbance from the Sample solution at time point i
As = absorbance from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
D = dilution factor for the Sample solution, if needed
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = [(C2 × V) + (C1 × Vs )] × (1/L) × 100
Result3 = {(C3 × V) + [(C2 + C1 ) × Vs ]} × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn at each time point and replaced with Medium (mL)
Tolerances: See Table 22.
Table 22
| Time Point (i) | Time (h) | Amount Dissolved (for Tablets that contain 150 mg of bupropion hydrochloride) (%) | Amount Dissolved (for Tablets that contain 300 mg of bupropion hydrochloride) (%) |
| 1 | 4 | NMT 20 | NMT 30 |
| 2 | 8 | 35-60 | 50-70 |
| 3 | 16 | NLT 80 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to Dissolution 〈711〉, Acceptance Table 2.
Test 22: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 22.
Acid stage medium: 0.1 N hydrochloric acid VS; 750 mL
Buffer stage medium: Sodium phosphate buffer, pH 6.8 (after 2 h, add 250 mL of 76 g/L of tribasic sodium phosphate, previously heated to 37 ± 0.5o, to the Acid stage medium and adjust with 2 N hydrochloric acid TS or 2 N sodium hydroxide TS, if necessary, to a pH of 6.8); 1000 mL
Apparatus 2: 50 rpm
Times: 2 h in Acid stage medium; 4 and 12 h in Buffer stage medium. The time in the Buffer stage medium includes the time in the Acid
stage medium.
Acid stage standard solution: 0.08 mg/mL of USP Bupropion Hydrochloride RS in Acid stage medium
Buffer stage standard solution: 0.3 mg/mL of USP Bupropion Hydrochloride RS in Buffer stage medium
Acid stage sample solution and Buffer stage sample solution: Use a portion of the solution under test.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength:
298 nm
Blank: Acid stage medium or Buffer stage medium
System suitability
Samples: Acid stage standard solution and Buffer stage standard solution
Suitability requirements
Relative standard deviation: NMT 2.0%, Acid stage standard solution and Buffer stage standard solution
Analysis
Samples: Acid stage standard solution, Buffer stage standard solution, Acid stage sample solution, and Buffer stage sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Ai/As ) × Cs × D
Ai = absorbance from the Acid stage sample solution or Buffer stage sample solution at time point i
As = absorbance from the Acid stage standard solution or Buffer stage standard solution at time point i
Cs = concentration of USP Bupropion Hydrochloride RS in the Acid stage standard solution or Buffer stage standard solution (mg/mL)
D = dilution factor, if needed
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved in Acid stage medium:
Result1 = C1 × VA × (1/L) × 100
C1 = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point 1
VA = volume of Acid stage medium, 750 mL
L = label claim (mg/Tablet)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result2 = {[C2 × (VB − VSA )] + (C1 × VSA )} × (1/L) × 100
Result3 = {[C3 × (VB − VSB − VSA )] + (C2 × VSB ) + (C1 × VSA )} × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
VB = volume of Buffer stage medium, 1000 mL
VSA = volume of Acid stage sample solution withdrawn at time point 1 (mL)
L = label claim (mg/Tablet)
VSB = volume of Buffer stage sample solution withdrawn at each time point (mL)
Tolerances: See Table 23.
Table 23
| Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 3 | NMT 15 |
| 2 | 4 | 40–60 |
| 3 | 12 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to Dissolution (711), Acceptance Table 2.
Test 23: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 23.
Acid stage medium: 0.1 N hydrochloric acid VS: 900 mL, deaerated
Buffer stage medium: pH 6.8 phosphate buffer 900 mL, deaerated
Apparatus 1: 75 rpm
Times: 2 h in Acid stage medium; 6 and 16 h in Buffer stage medium. The time in the Buffer stage medium includes the time in the Acid stage medium.
Acid stage standard solution: (1/900) mg/mL of USP Bupropion Hydrochloride RS in Acid stage medium, where L is the label claim, in mg/Tablet
Buffer stage standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Buffer stage medium, where L is the label claim, in mg/Tablet
Acid stage sample solution and Buffer stage sample solution: Pass a portion of the solution under test through a suitable filter.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV-Vis
Analytical wavelength: 298 nm
Cell: 0.5 cm, flow cell
Blank: Acid stage medium or Buffer stage medium
System suitability
Samples: Acid stage standard solution and Buffer stage standard solution
Suitability requirements
Relative standard deviation: NMT 2.0%, Acid stage standard solution and Buffer stage standard solution
Analysis
Samples: Acid stage standard solution, Buffer stage standard solution, Acid stage sample solution, and Buffer stage sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Ai/As ) × Cs
Ai = absorbance from the Acid stage sample solution or Buffer stage sample solution at time point i
As = absorbance from the Acid stage standard solution or Buffer stage standard solution at time point i
Cs = concentration of USP Bupropion Hydrochloride RS in the Acid stage standard solution or Buffer stage standard solution (mg/mL)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved in Acid stage medium (QA ):
Result1 = C1 × VA × (1/L) × 100
C1 = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point 1
VA = volume of Acid stage medium, 900 mL
L = label claim (mg/Tablet)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result2 = [C2 × VB × (1/L) × 100] + QA
Result3 = [C3 × VB × (1/L) × 100] + QA
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
VB = volume of Buffer stage medium, 900 mL
L = label claim (mg/Tablet)
QA = percentage of the labeled amount of bupropion hydrochloride dissolved in the Acid stage medium
Tolerances: See Table 24.
Table 24
| Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 2 | NMT 15 |
| 2 | 6 | 50-75 |
| 3 | 16 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to Dissolution (711), Acceptance Table 2.
Test 24: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 24.
Acid stage medium: 0.1 N hydrochloric acid: 900 mL, deaerated
Buffer stage medium: pH 6.8 phosphate buffer with 0.5 M sodium chloride (Dissolve 6.8 g of monobasic potassium phosphate and 0.9 g of sodium hydroxide in 1 L of water. Adjust with 0.2 M sodium hydroxide or phosphoric acid to a pH of 6.8. Add 29.2 g of sodium chloride.); 900 mL, deaerated
Apparatus 1: 50 rpm
Times
For Tablets labeled to contain 150 mg of bupropion hydrochloride: 2 h in Acid stage medium; 3, 5, 8, and 10 h in Buffer stage medium.
The time in the Buffer stage medium includes the time in the Acid stage medium.
For Tablets labeled to contain 300 mg of bupropion hydrochloride: 2 h in Acid stage medium; 3, 6, 10, and 16 h in Buffer stage medium.
The time in the Buffer stage medium includes the time in the Acid stage medium.
Acid stage standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Acid stage medium, where L is the label claim, in mg/Tablet. Sonicate to dissolve, if necessary. Pass the resulting solution through a suitable filter of 0.45-µm pore size, discarding the first 1 mL of filtrate. Use the solution within 1 h.
Buffer stage standard solution: (L/900) mg/mL of USP Bupropion Hydrochloride RS in Buffer stage medium, where L is the label claim, in mg/Tablet. Sonicate to dissolve, if necessary. Pass the resulting solution through a suitable filter of 0.45-µm pore size, discarding the first 1 mL of filtrate.
Acid stage sample solution: Pass a portion of the solution under test through a suitable filter of 0.45-µm pore size, discarding the first 1 mL of filtrate. Use the solution within 3 h. Remove the remainder of the solution under test from the vessel and proceed with testing in Buffer stage medium.
Buffer stage sample solution: Pass a portion of the solution under test through a suitable filter of 0.45-µm pore size, discarding the first 1 mL of filtrate. Replace the portion removed with the same volume of the Buffer stage medium.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV
Analytical wavelength: 298 nm
Cell: 0.5 cm
Blank: Acid stage medium or Buffer stage medium
Analysis
Samples: Acid stage standard solution, Buffer stage standard solution, Acid stage sample solution, and Buffer stage sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Au /As ) × Cs
Au = absorbance from the Acid stage sample solution or Buffer stage sample solution at time point i
As = absorbance from the Acid stage standard solution or Buffer stage standard solution at time point i
Cs = concentration of USP Bupropion Hydrochloride RS in the Acid stage standard solution or Buffer stage standard solution (mg/mL)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved in Acid stage medium (QA ):
Result1 = C1 × VA × (1/L) × 100
C1 = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point 1
VA = volume of Acid stage medium, 900 mL
L = label claim (mg/Tablet)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result2 = [C2 × VB × (1/L) × 100] + QA
Result3 = {[(C3 × VB ) + (C2 × VS )] × (1/L) × 100} + QA
Result4 = ({(C4 × VB ) + [(C3 + C2 ) × VS ]} × (1/L) × 100) + QA
Result5= ({(C5 × VB ) + [(C4 + C3 + C2 ) × VS ]} × (1/L) × 100) + QA
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
VB = volume of Buffer stage medium, 900 mL
L = label claim (mg/Tablet)
QA = percentage of the labeled amount of bupropion hydrochloride dissolved in the Acid stage medium
VS = volume of Sample solution withdrawn at each time point and replaced with Medium (mL)
Tolerances: See Table 25
Table 25
| Time Point (i) | For Tablets Labeled to Contain 150 mg of Bupropion Hydrochloride | For Tablets Labeled to Contain 300 mg of Bupropion Hydrochloride | ||
| Time (h) | Amount Dissolved (%) | Time (h) | Amount Dissolved (%) | |
| 1 | 2 | NMT 10 | 2 | NMT 10 |
| 2 | 3 | 11-31 | 3 | 5-25 |
| 3 | 5 | 41-61 | 6 | 29-49 |
| 4 | 8 | 64-84 | 10 | 58-78 |
| 5 | 10 | NLT 80 | 16 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to
Dissolution (711), Acceptance Table 2.
Test 25: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 25.
Medium: 0.1 N hydrochloric acid, 900 mL, deaerated
Apparatus 1: 75 rpm
Times: 2, 4, 8, and 12 h
Standard stock solution: 0.33 mg/mL of USP Bupropion Hydrochloride RS in Medium. Sonication may be used to promote dissolution.
Standard solution: 0.033 mg/mL of USP Bupropion Hydrochloride RS from Standard stock solution in Medium
Sample solution: Dilute a portion of the solution under test with Medium. Pass a portion of the resulting solution through a suitable filter of 0.45-µm pore size, discarding the first few milliliters of filtrate.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV
Analytical wavelength: 252 nm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci ) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Au /As ) × Cs × D
Au = absorbance from the Sample solution at time point i
As = absorbance from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
D = dilution factor for the Sample solution
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = {[C2 × (V − Vs )] + (C1 × Vs )} × (1/L) × 100
Result3 = ({C3 × [V − (2 × Vs )]} + [(C2 + C1 ) × Vs ]) × (1/L) × 100
Result4 = ({C4 × [V − (3 × Vs )]} + [(C3 + C2 + C1 ) × Vs ]) × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn at each time point (mL)
Tolerances: See Table 26.
Table 26
| Time Point (i) | Time (h) | Amount Dissolved (for Tablets that contain 150 mg of bupropion hydrochloride) (%) | Amount Dissolved (for Tablets that contain 300 mg of bupropion hydrochloride) (%) |
| 1 | 2 | NMT 15 | NMT 15 |
| 2 | 4 | 15-35 | 20-40 |
| 3 | 8 | 60-80 | 60-80 |
| 4 | 12 | NLT 80 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to Dissolution 〈711〉, Acceptance Table 2.
Test 26: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 26.
Medium: 0.1 N hydrochloric acid; 900 mL
Apparatus 1: 75 rpm
Times: 2, 6, and 14 h
Standard stock solution: 0.17 mg/mL of USP Bupropion Hydrochloride RS in Medium. Sonication may be used to promote dissolution.
Standard solution: 0.017 mg/mL of USP Bupropion Hydrochloride RS from Standard stock solution in Medium
Sample solution: Dilute a portion of the solution under test with Medium. Pass a portion of the resulting solution through a suitable lter of 0.45-μm pore size, discarding the rst few milliliters of ltrate. Replace the portion removed with the same volume of Medium.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy 〈857〉.)
Mode: UV-Vis
Analytical wavelength: 252 nm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci ) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at time point i:
Resulti = (Au /As ) × Cs × D
Au = absorbance from the Sample solution at time point i
As = absorbance from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
D = dilution factor for the Sample solution
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × Vs × (1/L) × 100
Result2 = [(C2 × V) + (C1 × Vs )] × (1/L) × 100
Result3 = {(C3 × V) + [(C2 + C1 ) × Vs ]} × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
V = volume of Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of Sample solution withdrawn at each time point and replaced with Medium (mL)
Tolerances: See Table 27.
Table 27
Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 2 | NMT 20 |
| 2 | 6 | 40–65 |
| 3 | 14 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specified conform to Dissolution (711) Acceptance Table 2.
Test 27: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 27.
Acid stage medium: 0.1 N hydrochloric acid: 750 mL, deaerated
Buffer stage medium: pH 6.8 phosphate buffer (Add 250 mL of solution containing 76 g of sodium phosphate, tribasic (dodecahydrate) in 1 L water to the Acid stage medium, adjust with 2 N sodium hydroxide or 2 N hydrochloric acid to a pH of 6.8, if necessary.); 1000 mL
Apparatus 2: 50 rpm with suitable sinkers
Times: 2 h in Acid stage medium, 4 and 12 h in Buffer stage medium. The time in the Buffer stage medium includes the time in the Acid stage medium.
Buffer: Dissolve 3.45 g of sodium phosphate, monobasic (monohydrate) in 1000 mL of water. Discard 4.0 mL of the solution, then add 4.0 ml of triethylamine and adjust with phosphoric acid to a pH of 2.8.
Mobile phase: Methanol and Buffer (55:45)
Standard solution: (L/1000) mg/ml. of USP Bupropion Hydrochloride RS in Acid stage medium, where L is the label claim, in mg/Tablet. Sonicate to dissolve.
Acid stage sample solution: At the time specified, withdraw a 10-ml, aliquot of the solution under test without replacing the withdrawn volume. Pass the withdrawn portion through a suitable filter of 10-um pore size.
Buffer stage sample solution: At the times specified, withdraw a 10-mL aliquot of the solution under test without replacing the withdrawn volume. Pass the withdrawn portions at each time point through a suitable filter of 10-um pore size.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 298 nm
Column: 4.6-mm × 15-cm; 5-µm packing L1
Column temperature: 30°
Flow rate: 1 mL/min
Injection volume: 20 µL
Run time: NLT 2.2 times the retention time of bupropion
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution, Acid stage sample solution, and Buffer stage sample solution
Calculate the concentration (Ci ) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at each time point (i):
Resulti = (ru /rs ) × Cs
ru = peak response of bupropion from the Acid stage sample solution or Buffer stage sample solution
rs = peak response of bupropion from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS from the Standard solution (mg/mL)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result1 = C1 × VA × (1/L) × 100
Result2 = {[C2 × (VB − Vs )] + (C1 × Vs )} × (1/L) × 100
Result3 = ({C3 × [VB − (2 × Vs )]} + [(C2 + C1 ) × Vs ]) × (1/L) × 100
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
VA = volume of Acid stage medium, 750 mL
L = label claim (mg/Tablet)
VB = volume of Buffer stage medium, 1000 mL
Vs = volume of Acid stage sample solution or Buffer stage sample solution withdrawn at each time point, 10 mL
Tolerances: See Table 28.
Table 28
Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 3 | NMT 25 |
| 2 | 4 | 40–60 |
| 3 | 12 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at the times specied conform to Dissolution 〈711〉, Acceptance Table 2.
Test 28: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 28.
Acid stage medium: 0.1 N hydrochloric acid; 750 mL, deaerated
Buffer stage medium: 0.05 M sodium phosphate buffer, pH 6.8 with 5 g/L of sodium dodecyl sulfate (Dissolve 38.3 g of sodium
phosphate, tribasic (dodecahydrate) in 100 mL of water and transfer to a 2-L container containing 1800 mL of water. Add 12.5 mL of hydrochloric acid and adjust with sodium hydroxide or hydrochloric acid to a pH of 6.8. Dilute with water to volume. To each liter of this solution, add 5 g of sodium dodecyl sulfate and dissolve by stirring NLT 30 min.); 1000 mL, deaerated
Apparatus 1: 75 rpm
Times: 1 h in Acid stage medium; 4, 8, and 16 h in Buffer stage medium. The time in the Buffer stage medium includes the time in the Acid stage medium.
Acid stage standard solution: 0.04 mg/mL of USP Bupropion Hydrochloride RS in Acid stage medium. Sonicate to dissolve.
Buffer stage standard solution: 0.15 mg/mL of USP Bupropion Hydrochloride RS in Buffer stage medium, Sonicate to dissolve..
Acid stage sample solution: At the time specified, withdraw a 10-mL aliquot of the solution under test and pass the withdrawn portion through a suitable filter of 10-um pore size. Transfer the basket containing the Tablet to the vessel containing Buffer stage medium and proceed with testing in Buffer stage medium.
Buffer stage sample solution: At the times specified, withdraw a 10-mL aliquot of the solution under test without replacing the withdrawn volume. Pass the withdrawn portions at each time point through a suitable filter of 70-µm pore size.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Mode: UV
Analytical wavelength:
252 nm
Cell: 0.1 cm
Blank: Acid stage medium or Buffer stage medium
Analysis
Samples: Acid stage standard solution, Buffer stage standard solution, Acid stage sample solution, and Buffer stage sample solution
Calculate the concentration (Ci) of bupropion hydrochloride (C13H18ClNO · HCl) in the sample withdrawn from the vessel at each time point (i):
Resulti = (Au /As ) × Cs
Au = absorbance from the Acid stage sample solution or Buffer stage sample solution
As = absorbance from the Acid stage standard solution or Buffer stage standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Acid stage standard solution or Buffer stage standard solution (mg/mL)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved in Acid stage medium (QA ):
Result1 = C1 × VA × (1/L) × 100
C1 = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point 1 (mg/mL)
VA = volume of Acid stage medium, 750 mL
L = label claim (mg/Tablet)
Calculate the percentage of the labeled amount of bupropion hydrochloride (C13H18ClNO · HCl) dissolved at each time point (i):
Result2 = [C2 × VB × (1/L) × 100] + QA
Result3 = ({[C3 × (VB − Vs )] + (C2 × Vs )} × (1/L) × 100) + QA
Result4 = [({C4 × [VB − (2 × Vs )]} + [(C2 + C3 ) × Vs ]) × (1/L) × 100] + QA
Ci = concentration of bupropion hydrochloride in the portion of the sample withdrawn at time point i (mg/mL)
VB = volume of Buffer stage medium, 1000 mL
L = label claim (mg/Tablet)
QA = percentage of the labeled amount of bupropion hydrochloride dissolved in the Acid stage medium
VB = volume of Buffer stage sample solution withdrawn at each time point, 10 mL
Tolerances: See Table 29.
Table 29
Time Point (i) | Time (h) | Amount Dissolved (%) |
| 1 | 1 | NMT 10 |
| 2 | 4 | 27–52 |
| 3 | 8 | 57–82 |
| 4 | 16 | NLT 80 |
The percentages of the labeled amount of bupropion hydrochloride (CHCINO HCI) dissolved at the times specified conform to Dissolution (711). Acceptance Table 2 (RB 1-Aug-2023)
UNIFORMITY OF DOSAGE UNITS (905): Meet the requirements
5 IMPURITIES
Change to read:
ORGANIC IMPURITIES
Diluent 1, Solution A, Solution B, Mobile phase, and either Sample stock solution A and Sample solution A or Buffer, Diluent 2, Sample
stock solution B, and Sample solution B: Proceed as directed in the Assay.
System suitability stock solution A: 0.02 mg/mL of USP Bupropion Related Compound C RS, 0.02 mg/mL of USP Bupropion Related Compound F. RS, and 0.012 mg/mL of USP 3-Chlorobenzoic Acid RS in methanol
System suitability solution A: 0.002 mg/mL of bupropion related compound C, 0.002 mg/mL of bupropion related compound F, and 0.0012 mg/mL of 3-chlorobenzoic acid from System suitability stock solution A in Diluent 1
System suitability stock solution B: 0.012 mg/mL of USP 3-Chlorobenzoic Acid RS in methanol
System suitability solution B: 0.0012 mg/mL of 3-chlorobenzoic acid from System suitability stock solution B in Diluent 1
Standard solution: 0.0012 mg/mL of USP Bupropion Hydrochloride RS in Diluent 1
Sensitivity solution: 0.0006 mg/mL of USP Bupropion Hydrochloride RS from Standard solution in Diluent 1
Chromatographic system: Proceed as directed in the Assay except use a Detector as follows.
Detector: UV 226 nm, adjusted ±2 nm so that the relative response factor requirement is met. [NOTE-The peak responses of the compounds of interest are very sensitive to changes in the detection wavelength.]
System suitability
Samples: System suitability solution A, System suitability solution B, Standard solution, and Sensitivity solution
[NOTE-See Table 30 (RB 1-Aug-2023) for the relative retention times.)
Suitability requirements
Resolution: NLT 1.3 between bupropion related compound F and bupropion related compound C, System suitability solution A; NLT 1.3 between bupropion related compound C and 3-chlorobenzoic acid, System suitability solution A
Relative standard deviation: NMT 10%, Standard solution
Relative response factor: 3.8-4.5 for the peak response of 3-chlorobenzoic acid in System suitability solution B divided by the peak response from bupropion in the Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: System suitability solution B, Standard solution, and Sample solution A or Sample solution B
Calculate the percentage of 3-chlorobenzoic acid in the portion of Tablets taken:
Result = (ru /rs ) × (Cs /Cu ) × 100
ru = peak response of 3-chlorobenzoic acid from Sample solution A or Sample solution B
rs = peak response of 3-chlorobenzoic acid from System suitability solution B
Cs = concentration of USP 3-Chlorobenzoic Acid RS in System suitability solution B (mg/mL)
Cu = nominal concentration of bupropion hydrochloride in Sample solution A or Sample solution B (mg/mL)
Calculate the percentage of each other degradation product in the portion of Tablets taken:
Result = (ru /rs ) × (Cs /Cu ) × (1/F) × 100
ru = peak response of each other degradation product from Sample solution A or Sample solution B
rs = peak response of bupropion hydrochloride from the Standard solution
Cs = concentration of USP Bupropion Hydrochloride RS in the Standard solution (mg/mL)
Cu = nominal concentration of bupropion hydrochloride in Sample solution A or Sample solution B (mg/mL)
F = relative response factor for each other degradation product (see Table 30 (RB 1-Aug-2023) )
Acceptance criteria: See Table 30 (RB 1-Aug-2023) . The reporting threshold is 0.10%.
Table 30 (RB 1-Aug-2023)
Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) | |
| 100 mg or less | 150 mg or greater | |||
| Bupropion aminea | 0.38 | 1.2 | 0.3 | 0.3 |
| S,S,S-Thiomorpholine derivativeb | 0.56 | 1.1 | 1.0 | 1.5 |
| S,R,R-Thiomorpholine derivativec | 0.78 | 1.1 | 0.5 | 0.4 |
| Bupropion | 1.0 | - | - | - |
| Bupropion related compound F | 1.71 | 1.8 | 1.2 | 2.3 |
| Bupropion related compound C | 1.75 | 1.7 | 0.3 | 0.3 |
| 3-Chlorobenzoic acid | 1.80 | 0.5 | 0.5 | |
| Bupropion dione derivatived | 2.25 | 1.00 | 0.4 | 0.4 |
| Any unspecied degradation product | - | 1.00 | 0.2 | 0.2 |
| Total impurities | - | - | 3.2 | 3.3 |
a 2-Amino-1-(3-chlorophenyl)-1-propanone.
b (3S,5S,6S)-6-(3-Chlorophenyl)-6-hydroxy-5-methyl-3-thiomorpholine carboxylic acid.
c (3S,5R,6R)-6-(3-Chlorophenyl)-6-hydroxy-5-methyl-3-thiomorpholine carboxylic acid.
d 1-(3-Chlorophenyl)propane-1,2-dione.
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed containers. Store at controlled room temperature. Protect from light.
Labeling: The labeling states the Dissolution test used only if Test 1 is not used.
USP Reference Standards 〈11〉
USP Bupropion Hydrochloride RS
USP Bupropion Related Compound C RS
[Note—May also be labeled as USP Bupropion Hydrochloride Related Compound C RS.]
1-(3-Chlorophenyl)-2-hydroxypropan-1-one.
C9H9O2Cl 184.62
USP Bupropion Related Compound F RS
[Note—May also be labeled as USP Bupropion Hydrochloride Related Compound F RS.]
1-(3-Chlorophenyl)-1-hydroxypropan-2-one.
C9H9O2Cl 184.62
USP 3-Chlorobenzoic Acid RS
3-Chlorobenzoic acid.
C7H5ClO2 156.57

